Anixa Biosciences Inc 8-K

What Happened

• Anixa Biosciences, Inc. filed an 8-K on March 11, 2026 reporting results from its March 10, 2026 annual meeting of stockholders. Of 33,379,505 shares entitled to vote, 20,805,324 shares were present or represented by valid proxy.
• Stockholders re-elected four directors — Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. — each to serve until the 2027 annual meeting. The re-elections carried with the following vote tallies:
  • Dr. Amit Kumar: 8,917,813 For; 218,238 Withheld; 11,669,273 Broker Non-Votes
  • Dr. Arnold Baskies: 7,425,900 For; 1,710,151 Withheld; 11,669,273 Broker Non-Votes
  • Emily Gottschalk: 7,249,290 For; 1,886,761 Withheld; 11,669,273 Broker Non-Votes
  • Lewis H. Titterton, Jr.: 7,176,739 For; 1,959,312 Withheld; 11,669,273 Broker Non-Votes
• By non-binding advisory vote, stockholders approved the company’s executive compensation (6,025,247 For; 2,973,752 Against; 137,032 Abstentions; 11,669,273 Broker Non-Votes).
• Stockholders ratified Haskell & White LLP as Anixa’s independent registered public accounting firm for the fiscal year ending October 31, 2026 (20,426,524 For; 191,432 Against; 187,368 Abstaining).
• The company also attached the presentation used at the meeting (Exhibit 99.1) under Regulation FD disclosure.

Key Details

• Total shares entitled to vote: 33,379,505; shares represented at meeting: 20,805,324.
• Four directors re-elected; individual "For" votes ranged from ~7.18M to ~8.92M.
• Advisory approval of executive pay: ~6.03M For vs. ~2.97M Against (non-binding).
• Auditor ratification: ~20.43M For, confirming Haskell & White LLP for FY ending Oct 31, 2026.

Why It Matters

• Board continuity: re-election of all four directors keeps current governance team in place, which can matter for strategy and oversight continuity.
• Advisory approval of executive compensation signals majority shareholder support for pay practices, though the vote is non-binding and does not legally change compensation.
• Ratification of the auditor provides assurance that the company will continue with Haskell & White LLP for the coming fiscal year’s audit process.
• The attached presentation may be used in future investor communications and can provide additional context about the company’s plans and progress.